PhoreMost is a company specializing in drug discovery. It develops the SiteSeeker technology, which is a live-cell phenotypic assay system that can rapidly identify druggable sites in specific disease driving targets and pathways that can’t be readily seen using conventional non-cell based analytical methods. SiteSeeker employs diverse biological screening libraries of small 3-dimensional protein-folds, which when delivered into cell-based phenotypic assays interact on a genome-wide scale with host-cell proteins to describe new druggable space that is intimately linked to disease causation.
|Employees (est.) (Jan 2021)||33||(+7%)|
PhoreMost total Funding
Time since last funding
|2 years ago|
|Amadeus Capital Partners, Jonathan Milner, University of Cambridge Enterprise, Morningside Venture Capital, Parkwalk Advisors|
|GBP||FY, 2015||FY, 2017||FY, 2018||FY, 2019|
PhoreMost has 354 Twitter Followers. The number of followers has increased 2.5% month over month and increased 4.8% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was PhoreMost founded?
PhoreMost was founded in 2014.
How many employees does PhoreMost have?
PhoreMost has 33 employees.
Who are PhoreMost competitors?
Competitors of PhoreMost include GT Biopharma, Emisphere Technologies and Otonomy.
Where is PhoreMost headquarters?
PhoreMost headquarters is located at Babraham Hall, Babraham.
Where are PhoreMost offices?
PhoreMost has an office in Babraham.
How many offices does PhoreMost have?
PhoreMost has 1 office.
Receive alerts for 300+ data fields across thousands of companies